Journal of Internal Medicine Concepts & Practice >
Clinical diagnosis and treatment progress of hypoglycemia caused by non-islet cell tumors
ZHANG Jie, LU Jieli . Clinical diagnosis and treatment progress of hypoglycemia caused by non-islet cell tumors[J]. Journal of Internal Medicine Concepts & Practice, 2023 , 18(04) : 256 -260 . DOI: 10.16138/j.1673-6087.2023.04.009
[1] | de Groot JW, Rikhof B, van Doorn J, et al. Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases[J]. Endocr Relat Cancer, 2007, 14(4): 979-993. |
[2] | Baldwin RS. Hypoglycemia with neoplasia (doege-potter syndrome)[J]. Wis Med J, Wis Med J, 1965, 64: 185-189. |
[3] | Bodnar TW, Acevedo MJ, Pietropaolo M. Management of non-islet-cell tumor hypoglycemia: a clinical review[J]. J Clin Endocrinol Metab, 2014, 99(3): 713-722. |
[4] | Fukuda I, Hizuka N, Ishikawa Y, et al. Clinical features of insulin-like growth factor-Ⅱ producing non-islet-cell tumor hypoglycemia[J]. Growth Horm IGF Res, 2006, 16(4): 211-216. |
[5] | Rastogi MV, Desai N, Quintos JB. Non-islet-cell tumor hypoglycemia and lactic acidosis in a child with congenital HIV and Burkitt’s lymphoma[J]. J Pediatr Endocrinol Metab, 2008, 21(8): 805-810. |
[6] | Agus MS, Katz LE, Satin-Smith M, et al. Non-islet-cell tumor associated with hypoglycemia in a child: successful long-term therapy with growth hormone[J]. J Pediatr, 1995, 127(3): 403-407. |
[7] | Korn E, Van Hoff J, Buckley P, et al. Secretion of a large molecular-weight form of insulin-like growth factor by a primary renal tumor[J]. Med Pediatr Oncol, 1995, 24(6): 392-396. |
[8] | Teale JD, Marks V. Glucocorticoid therapy suppresses abnormal secretion of big IGF-Ⅱ by non-islet cell tumours inducing hypoglycaemia(NICTH)[J]. Clin Endocrinol (Oxf), 1998, 49(4): 491-498. |
[9] | Phillips LS, Robertson DG. Insulin-like growth factors and non-islet cell tumor hypoglycemia[J]. Metabolism, 1993, 42(9): 1093-1101. |
[10] | 陆洁莉, 赵咏桔, 唐金凤, 等. 胰岛素样生长因子Ⅱ过度分泌引起的非胰岛细胞肿瘤性低血糖——2例报告与文献复习[J]. 中华内分泌代谢杂志, 2004, 20(3): 234-235. |
[11] | 陆洁莉, 刘建民, 方文强, 等. 非胰岛细胞肿瘤所致低血糖一例及文献复习[J]. 中华内分泌代谢杂志, 2016, 32(4): 330-334. |
[12] | Shapiro ET, Bell GI, Polonsky KS, et al. Tumor hypoglycemia: relationship to high molecular weight insulin-like growth factor-Ⅱ[J]. J Clin Invest, 1990, 85(5): 1672-1679. |
[13] | Rosseel L, De Leu N, van Hecke W, et al. A rare case of hypoglycemia in a patient with elevated right hemidiaphragm[J]. BMJ Case Rep, 2012, 2012: bcr0320125972. |
[14] | Zafar H, Takimoto CH, Weiss G. Doege-Potter syndrome: hypoglycemia associated with malignant solitary fibrous tumor[J]. Med Oncol, 2003, 20(4): 403-408. |
[15] | Dynkevich Y, Rother KI, Whitford I, et al. Tumors, IGF-2, and hypoglycemia: insights from the clinic, the laboratory, and the historical archive[J]. Endocr Rev, 2013, 34(6): 798-826. |
[16] | Kalebi AY, Hale MJ, Wong ML, et al. Surgically cured hypoglycemia secondary to pleural solitary fibrous tumour: case report and update review on the Doege-Potter syndrome[J]. J Cardiothorac Surg, 2009, 4: 45. |
[17] | Daughaday WH, Emanuele MA, Brooks MH, et al. Synthesis and secretion of insulin-like growth factor Ⅱ by a leiomyosarcoma with associated hypoglycemia[J]. N Engl J Med, 1988, 319(22): 1434-1440. |
[18] | Baxter RC. The role of insulin-like growth factors and their binding proteins in tumor hypoglycemia[J]. Horm Res, 1996, 46(4-5): 195-201. |
[19] | Bertherat J, Logié A, Gicquel C, et al. Alterations of the 11p15 imprinted region and the IGFs system in a case of recurrent non-islet-cell tumour hypoglycaemia (NICTH)[J]. Clin Endocrinol (Oxf), 2000, 53(2): 213-220. |
[20] | Tani Y, Tateno T, Izumiyama H, et al. Defective expression of prohormone convertase 4 and enhanced expression of insulin-like growth factor Ⅱ by pleural solitary fibrous tumor causing hypoglycemia[J]. Endocr J, 2008, 55(5): 905-911. |
[21] | Hoekman K, van Doorn J, Gloudemans T, et al. Hypoglycaemia associated with the production of insulin-like growth factor Ⅱ and insulin-like growth factor binding protein 6 by a haemangiopericytoma[J]. Clin Endocrinol (Oxf), 1999, 51(2): 247-253. |
[22] | Zachariah S, Brackenridge A, Shojaee-Moradie F, et al. The mechanism of non-islet cell hypoglycaemia caused by tumour-produced IGF-Ⅱ[J]. Clin Endocrinol (Oxf), 2007, 67(4): 637-638. |
[23] | LeRoith D, Roberts CT Jr. The insulin-like growth factor system and cancer[J]. Cancer Lett, 2003, 195(2): 127-137. |
[24] | Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline[J]. J Clin Endocrinol Metab, 2009, 94(3): 709-728. |
[25] | Kageyama K, Moriyama T, Hizuka N, et al. Hypoglycemia associated with big insulin-like growth factor Ⅱ produced during development of malignant fibrous histiocytoma[J]. Endocr J, 2003, 50(6): 753-758. |
[26] | Tsuro K, Kojima H, Okamoto S, et al. Glucocorticoid therapy ameliorated hypoglycemia in insulin-like growth factor-Ⅱ-producing solitary fibrous tumor[J]. Intern Med, 2006, 45(8): 525-529. |
[27] | Bessell EM, Selby C, Ellis IO. Severe hypoglycaemia caused by raised insulin-like growth factor Ⅱ in disseminated breast cancer[J]. J Clin Pathol, 1999, 52(10): 780-781. |
[28] | Escobar GA, Robinson WA, Nydam TL, et al. Severe paraneoplastic hypoglycemia in a patient with a gastrointestinal stromal tumor with an exon 9 mutation[J]. BMC Cancer, 2007, 7: 13. |
[29] | Barra WF, Castro G, Hoff AO, et al. Symptomatic hypoglycemia related to inappropriately high IGF-Ⅱ serum levels in a patient with desmoplastic small round cell tumor[J]. Case Rep Med, 2010, 2010: 684045. |
[30] | Hunter SJ, Daughaday WH, Callender ME, et al. A case of hepatoma associated with hypoglycaemia and overproduction of IGF-Ⅱ(E-21): beneficial effects of treatment with growth hormone and intrahepatic adriamycin[J]. Clin Endocrinol (Oxf), 1994, 41(3): 397-401. |
[31] | Kishi K, Sonomura T, Sato M. Radiotherapy for hypoglycaemia associated with large leiomyosarcomas[J]. Br J Radiol, 1997, 70: 306-308. |
[32] | Teale JD, Wark G. The effectiveness of different treatment options for non-islet cell tumour hypoglycaemia[J]. Clin Endocrinol (Oxf), 2004, 60(4): 457-460. |
[33] | Powter L, Phillips S, Husbands E. A case report of non-islet cell tumour hypoglycaemia associated with ovarian germ-cell tumour[J]. Palliat Med, 2013, 27(3): 281-283. |
[34] | Mukherjee S, Diver M, Weston PJ. Non islet cell tumor hypoglycaemia in a metastatic Leydig cell tumor[J]. Acta Oncol, 2005, 44(7): 761-763. |
[35] | Perros P, Simpson J, Innes JA, et al. Non-islet cell tumour-associated hypoglycaemia: 111In-octreotide imaging and efficacy of octreotide, growth hormone and glucocorticosteroids[J]. Clin Endocrinol (Oxf), 1996, 44(6): 727-731. |
[36] | Silveira LF, Bouloux PM, MacColl GS, et al. Growth hormone therapy for non-islet cell tumor hypoglycemia[J]. Am J Med, 2002, 113(3): 255-257. |
[37] | Teale JD, Blum WF, Marks V. Alleviation of non-islet cell tumour hypoglycaemia by growth hormone therapy is associated with changes in IGF binding protein-3[J]. Ann Clin Biochem, 1992, 29 Pt 3: 314-323. |
[38] | Drake WM, Miraki F, Siddiqi A, et al. Dose-related effects of growth hormone on IGF-Ⅰ and IGF-binding protein-3 levels in non-islet cell tumour hypoglycaemia[J]. Eur J Endocrinol, 1998, 139(5): 532-536. |
[39] | Bourcigaux N, Arnault-Ouary G, Christol R, et al. Treatment of hypoglycemia using combined glucocorticoid and recombinant human growth hormone in a patient with a metastatic non-islet cell tumor hypoglycemia[J]. Clin Ther, 2005, 27(2): 246-251. |
[40] | Baxter RC, Holman SR, Corbould A, et al. Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia[J]. J Clin Endocrinol Metab, 1995, 80(9): 2700-2708. |
[41] | Sullivan DH, Carter WJ, Warr WR, et al. Side effects resulting from the use of growth hormone and insulin-like growth factor-Ⅰ as combined therapy to frail elderly patients[J]. J Gerontol A Biol Sci Med Sci, 1998, 53(3): M183-M187. |
[42] | Scott K. Non-islet cell tumor hypoglycemia[J]. J Pain Symptom Manage, 2009, 37(4): e1-e3. |
[43] | F?ger B, Zapf J, Lechleitner M, et al. Prevention with glucocorticoids of extrapancreatic tumour-hypoglycaemia as a result of increased ‘big’ insulin-like growth factor Ⅱ[J]. J Intern Med, 1994, 236(6): 692-693. |
[44] | Goode PN, Farndon JR, Anderson J, et al. Diazoxide in the management of patients with insulinoma[J]. World J Surg, 1986, 10(4): 586-592. |
[45] | Davda R, Seddon BM. Mechanisms and management of non-islet cell tumour hypoglycaemia in gastrointestinal stromal tumour: case report and a review of published studies[J]. Clin Oncol (R Coll Radiol), 2007, 19(4): 265-268. |
[46] | Davda R, Seddon BM. Mechanisms and management of non-islet cell tumour hypoglycaemia in gastrointestinal stromal tumour: case report and a review of published studies[J]. Clin Oncol (R Coll Radiol), 2007, 19(4): 265-268. |
[47] | Sturrock ND, Selby C, Hosking DJ. Spontaneous hypoglycaemia in a noninsulin-dependent diabetes mellitus patient with disseminated pancreatic carcinoma[J]. Diabet Med, 1997, 14(4): 324-326. |
[48] | Krishnan L, Clark J. Non-islet cell tumour hypoglycaemia[J]. BMJ Case Rep, 2011, 2011: bcr0220113914. |
[49] | Ishikura K, Takamura T, Takeshita Y, et al. Cushing’s syndrome and big IGF-Ⅱ associated hypoglycaemia in a patient with adrenocortical carcinoma[J]. BMJ Case Rep, 2010, 2010: bcr07. |
[50] | Morbois-Trabut L, Maillot F, De Widerspach-Thor A, et al. “Big IGF-Ⅱ”-induced hypoglycemia secondary to gastric adenocarcinoma[J]. Diabetes Metab, 2004, 30(3): 276-279. |
/
〈 |
|
〉 |